| 5501 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5502 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
40 |
| 5503 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5504 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
72 |
| 5505 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
50 |
| 5506 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
59 |
| 5507 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5508 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5509 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 5510 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
68 |
| 5511 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5512 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
56 |
| 5513 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
63 |
| 5514 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5515 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
64 |
| 5516 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 5517 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
68 |
| 5518 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5519 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
68 |
| 5520 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5521 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5522 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5523 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
67 |
| 5524 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
4 |
| 5525 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
56 |
| 5526 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5527 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5528 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5529 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5530 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
63 |
| 5531 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
44 |
| 5532 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5533 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
33 |
| 5534 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5535 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5536 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
49 |
| 5537 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
69 |
| 5538 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
71 |
| 5539 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
25 |
| 5540 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 5541 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
46 |
| 5542 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5543 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Germany |
49 |
| 5544 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5545 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5546 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Germany |
67 |
| 5547 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5548 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome – Raeb |
Hematology |
2019 |
Standard Therapy |
Poland |
21 |
| 5549 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome – Raeb |
Hematology |
2019 |
Standard Therapy |
Poland |
16 |
| 5550 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome; Myeloproliferative Neoplasms Overlap |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5551 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
46 |
| 5552 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5553 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
47 |
| 5554 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
33 |
| 5555 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5556 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
43 |
| 5557 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5558 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
69 |
| 5559 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
63 |
| 5560 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5561 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5562 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5563 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5564 |
Apheresis |
Autologous |
Myeloma; Amyloidosis |
Hematology |
2019 |
Standard Therapy |
Germany |
47 |
| 5565 |
Apheresis |
Autologous |
Natural Killer / T-Cell-Non-Hodgkin-Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
32 |
| 5566 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
43 |
| 5567 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
20 |
| 5568 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5569 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
68 |
| 5570 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
28 |
| 5571 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5572 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
67 |
| 5573 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
51 |
| 5574 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5575 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 5576 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
55 |
| 5577 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5578 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5579 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5580 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
69 |
| 5581 |
Apheresis |
Allogeneic |
Osteomyelofibrosis – Other |
Hematology |
2019 |
Standard Therapy |
Poland |
63 |
| 5582 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
70 |
| 5583 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5584 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
50 |
| 5585 |
Apheresis |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria (Pnh) |
Hematology |
2019 |
Standard Therapy |
Poland |
24 |
| 5586 |
Apheresis |
Allogeneic |
Plasma Cell Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
35 |
| 5587 |
Apheresis |
Allogeneic |
Polycythemia Vera-Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
58 |
| 5588 |
Apheresis |
Allogeneic |
Post–Polycythemia Vera Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
70 |
| 5589 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
65 |
| 5590 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5591 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
69 |
| 5592 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5593 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5594 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
57 |
| 5595 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5596 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
67 |
| 5597 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
78 |
| 5598 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
21 |
| 5599 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
19 |
| 5600 |
Apheresis |
Allogeneic |
Primary Mediastinal |
Hematology |
2019 |
Standard Therapy |
Poland |
33 |